Last reviewed · How we verify
NCT05748665
Effect of Remimazolam on the Recovery Quality After Day Surgery
NA trial testing Remimazolam besylate in Elderly Patients in 118 participants. Completed in 26 January 2024.
24 January 2024
Quick facts
| Lead sponsor | Xijing Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 118 |
| Start date | 14 August 2023 |
| Primary completion | 24 January 2024 |
| Estimated completion | 26 January 2024 |
| Sites | 3 locations across China |
Drugs / interventions tested
- Remimazolam besylate — full drug profile →
- etomidate (ETOMIDATE) — full drug profile →
Conditions studied
- Elderly Patients — all drugs for Elderly Patients →
- Ambulatory Surgery — all drugs for Ambulatory Surgery →
Sponsor
Xijing Hospital
Who can join
60 and older, any sex, with Elderly Patients or Ambulatory Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare remimazolam and etomidate in inducing quality of recovery after day surgery for laryngeal mask general anesthesia in elderly patients. The main question it aims to answer is: • The quality of postoperative recovery induced by remimazolam for laryngeal mask general anesthesia in elderly patients undergoing day surgery is not inferior to that induced by etomidate Participants will be given remimazolam to induce anesthesia。 Researchers will compare etomidate to see if the quality of postoperative recovery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Quality of Postoperative Recovery in Older Patients Undergoing Day Surgery: A Randomized, Non-Inferiority Trial of Remimazolam versus Etomidate for Anesthesia Induction.
Liu J, Hu S, Zhang E, Zhang P, et al · · 2025 · PMID 41262435 · DOI 10.2147/cia.s551569
Verify or expand the search:
- PubMed search for NCT05748665
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Remimazolam besylate
Trials testing the same drug.
- NCT07213544 — Remimazolam vs Propofol in Laser Burn Cases · Phase 4 · recruiting
- NCT07456111 — A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy · Phase 4 · recruiting
- NCT06427785 — The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate · not yet recruiting
- NCT06359834 — Comparison of Remimazolam and Propofol Effect on Oxygen Reserve During Endoscopic Retrograde Cholangiopancreatography · NA · completed
- NCT05975255 — Dose Finding Study for Remimazolam in Children · Phase 2 · unknown
Other recruiting trials for Elderly Patients
Currently open trials in the same condition.
- NCT07108764 — Intraoperative Infusion of Either Lidocaine or Dexmedetomidine on Regional Cerebral Oxygen Saturation and Postoperative · NA · recruiting
- NCT06768580 — Effect of Oral Melatonin Versus Intraoperative Lidocaine Infusion on Incidence of Postoperative Delirium in Elderly Pati · NA · recruiting
- NCT06677645 — Evaluation of Medical and Social Care for Elderly Patients, Between Hospital and Home: TEMPORARY ACCOMMODATION Out of Ho · recruiting
- NCT07514936 — Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia · Phase 2 · recruiting
- NCT06413342 — Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma · Phase 2 · recruiting
Other Xijing Hospital trials
Trials by the same sponsor.
- NCT07532096 — Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast · NA · not yet recruiting
- NCT07519018 — TIS for Drug Resistant TLE · NA · not yet recruiting
- NCT07518992 — Correlation Between Preoperative Sleep and Postoperative Brain and Renal Dysfunction · not yet recruiting
- NCT07466303 — Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer · Phase 2 · not yet recruiting
- NCT07474142 — A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve P · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05748665 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xijing Hospital
- Last refreshed: 13 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748665.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing